These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29962813)

  • 81. Infections and organ transplantation: new challenges for prevention and treatment of hepatitis C virus.
    Burra P; De Martin E
    Transplant Proc; 2011; 43(6):2455-6. PubMed ID: 21839292
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Limiting the access to direct-acting antivirals against HCV: an ethical dilemma.
    Gentile I; Maraolo AE; Niola M; Graziano V; Borgia G; Paternoster M
    Expert Rev Gastroenterol Hepatol; 2016 Nov; 10(11):1227-1234. PubMed ID: 27607920
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C.
    Mauro E; Crespo G; Montironi C; Londoño MC; Hernández-Gea V; Ruiz P; Sastre L; Lombardo J; Mariño Z; Díaz A; Colmenero J; Rimola A; Garcia-Pagán JC; Brunet M; Forns X; Navasa M
    Hepatology; 2018 May; 67(5):1683-1694. PubMed ID: 28960366
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Hepatitis C virus infection in children and adolescents.
    Indolfi G; Easterbrook P; Dusheiko G; El-Sayed MH; Jonas MM; Thorne C; Bulterys M; Siberry G; Walsh N; Chang MH; Meyers T; Giaquinto C; Wirth S; Chan PL; Penazzato M
    Lancet Gastroenterol Hepatol; 2019 Jun; 4(6):477-487. PubMed ID: 30982721
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Cirrhosis of the liver and HCV].
    Hejda V
    Vnitr Lek; 2015 Nov; 61 Suppl 4():4s13-23. PubMed ID: 26667616
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Tools for the diagnosis of hepatitis C virus infection and hepatic fibrosis staging.
    Saludes V; González V; Planas R; Matas L; Ausina V; Martró E
    World J Gastroenterol; 2014 Apr; 20(13):3431-42. PubMed ID: 24707126
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Highlights of the guidelines of prevention and treatment for hepatitis C (2019 version)].
    Rao HY; Duan ZP; Wang GQ; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2020 Feb; 28(2):129-132. PubMed ID: 32164062
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Expert advices for evaluating clinical trials of direct-acting antiviral agents for hepatitis C].
    Research Group for New Drug's Clinical Evalutaion of Critical Diseases and Platform Construction of Integrated Technology
    Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):161-4. PubMed ID: 27095756
    [No Abstract]   [Full Text] [Related]  

  • 89. Hepatitis C Virus Infection in the Older Patient.
    Reid M; Price JC; Tien PC
    Infect Dis Clin North Am; 2017 Dec; 31(4):827-838. PubMed ID: 29079161
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pharmacology Update for the Treatment of Hepatitis C Virus.
    Hopkins L; Dunlap T; Cline H
    Nurs Clin North Am; 2020 Sep; 55(3):347-359. PubMed ID: 32762855
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Current status of the prevalence, diagnosis, and treatment of hepatitis C in patients undergoing hemodialysis].
    Yang GL; Lei XZ
    Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):233-236. PubMed ID: 28482415
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Treatment and monitoring of children with chronic hepatitis C in the Pre-DAA era: A European survey of 38 paediatric specialists.
    Indolfi G; Bailey H; Serranti D; Giaquinto C; Thorne C;
    J Viral Hepat; 2019 Aug; 26(8):961-968. PubMed ID: 30980773
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Chronic hepatitis C infection - Noninvasive assessment of liver fibrosis in the era of direct acting antivirals.
    Trivedi HD; Patwardhan VR; Malik R
    Dig Liver Dis; 2019 Feb; 51(2):183-189. PubMed ID: 30553749
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
    Jonas MC; Loftus B; Horberg MA
    Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment Modalities.
    Manka P; Zeller A; Syn WK
    Drugs; 2019 Jun; 79(9):903-927. PubMed ID: 31119644
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hepatitis C Virus Diagnosis and the Holy Grail.
    Applegate TL; Fajardo E; Sacks JA
    Infect Dis Clin North Am; 2018 Jun; 32(2):425-445. PubMed ID: 29778264
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Hepatitis C virus infection and new treatment strategies.
    García Deltoro M; Ricart Olmos C
    Enferm Infecc Microbiol Clin (Engl Ed); 2019 May; 37 Suppl 1():15-19. PubMed ID: 31138418
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Guidelines for the prevention and treatment of hepatitis C (2019 version)].
    ;
    Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):962-979. PubMed ID: 31941258
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Eradicating hepatitis C: The need for a public health response.
    Wallace J; Richmond J; Ellard J; Power J; Lucke J
    Glob Public Health; 2018 Sep; 13(9):1254-1264. PubMed ID: 30012072
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Current and forthcoming perspectives in linkage to care of hepatitis C virus infection: Assessment of an Italian focus group.
    Andreone P; Di Marco V; Gaeta GB; Fagiuoli S; Vukotic R; Craxì A
    Dig Liver Dis; 2019 Jul; 51(7):915-921. PubMed ID: 31031174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.